Literature DB >> 18781958

Chagas heart disease pathogenesis: one mechanism or many?

Kevin M Bonney1, David M Engman.   

Abstract

Chagas heart disease (CHD), caused by the protozoan parasite Trypanosoma cruzi, is the leading cause of infectious myocarditis in the world. The etiology of CHD is unclear and multiple mechanisms have been proposed to explain the pathogenesis of the disease. This review describes the proposed mechanisms of CHD pathogenesis and evaluates the historical significance and evidence supporting each. Although the majority of CHD-related pathologies are currently attributed to parasite persistence in the myocardium and autoimmunity, there is strong evidence that CHD develops as a result of additive and even synergistic effects of several distinct mechanisms rather than one factor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18781958      PMCID: PMC2859714          DOI: 10.2174/156652408785748004

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  69 in total

1.  Induction of antibodies reactive to cardiac myosin and development of heart alterations in cruzipain-immunized mice and their offspring.

Authors:  L Giordanengo; C Maldonado; H W Rivarola; D Iosa; N Girones; M Fresno; S Gea
Journal:  Eur J Immunol       Date:  2000-11       Impact factor: 5.532

Review 2.  American trypanosomiasis (Chagas' disease) and the role of molecular epidemiology in guiding control strategies.

Authors:  Michael A Miles; M Dora Feliciangeli; Antonieta Rojas de Arias
Journal:  BMJ       Date:  2003-06-28

3.  [Chagas disease: a disease of the peripheral autonomic nervous system].

Authors:  F KOBERLE
Journal:  Wien Klin Wochenschr       Date:  1956-04-27       Impact factor: 1.704

4.  Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease.

Authors:  Kellen C Faé; Danielle Diefenbach da Silva; Sandra E Oshiro; Ana C Tanaka; Pablo M A Pomerantzeff; Corinne Douay; Dominique Charron; Antoine Toubert; Madeleine W Cunningham; Jorge Kalil; Luiza Guilherme
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

5.  Parasite persistence correlates with disease severity and localization in chronic Chagas' disease.

Authors:  L Zhang; R L Tarleton
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

6.  Cardiac myosin autoimmunity in acute Chagas' heart disease.

Authors:  J S Leon; L M Godsel; K Wang; D M Engman
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

7.  Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice.

Authors:  Joshua Kotner; Rick Tarleton
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

8.  Analysis of the presence of Trypanosoma cruzi in the heart tissue of three patients with chronic Chagas' heart disease.

Authors:  Fernando E Elias; Carlos A Vigliano; Rubén P Laguens; Mariano J Levin; Claudia Berek
Journal:  Am J Trop Med Hyg       Date:  2003-02       Impact factor: 2.345

9.  In vitro culture of cardiac mast cells from mice experimentally infected with Trypanosoma cruzi.

Authors:  M Postan; R Correa; V J Ferrans; R L Tarleton
Journal:  Int Arch Allergy Immunol       Date:  1994-11       Impact factor: 2.749

10.  Cell-mediated cytotoxicity to Trypanosoma cruzi. II. Antibody-dependent killing of bloodstream forms by mouse eosinophils and neutrophils.

Authors:  T L Kipnis; S L James; A Sher; J R David
Journal:  Am J Trop Med Hyg       Date:  1981-01       Impact factor: 2.345

View more
  60 in total

Review 1.  Chagas heart disease: report on recent developments.

Authors:  Fabiana S Machado; Linda A Jelicks; Louis V Kirchhoff; Jamshid Shirani; Fnu Nagajyothi; Shankar Mukherjee; Randin Nelson; Christina M Coyle; David C Spray; Antonio C Campos de Carvalho; Fangxia Guan; Cibele M Prado; Michael P Lisanti; Louis M Weiss; Susan P Montgomery; Herbert B Tanowitz
Journal:  Cardiol Rev       Date:  2012 Mar-Apr       Impact factor: 2.644

2.  Identification of Structure-Stabilizing Interactions in Enzymes: A Novel Mechanism to Impact Enzyme Activity.

Authors:  Marisol Serrano; Veronica Gonzalez; Supriyo Ray; Maria D Chavez; Mahesh Narayan
Journal:  Cell Biochem Biophys       Date:  2017-07-29       Impact factor: 2.194

Review 3.  Immunity and immune modulation in Trypanosoma cruzi infection.

Authors:  Fabíola Cardillo; Rosa Teixeira de Pinho; Paulo Renato Zuquim Antas; José Mengel
Journal:  Pathog Dis       Date:  2015-10-04       Impact factor: 3.166

Review 4.  Autoimmune pathogenesis of Chagas heart disease: looking back, looking ahead.

Authors:  Kevin M Bonney; David M Engman
Journal:  Am J Pathol       Date:  2015-04-07       Impact factor: 4.307

Review 5.  Diagnosis and Management of Chagas Cardiomyopathy in the United States.

Authors:  Lillian Benck; Evan Kransdorf; Jignesh Patel
Journal:  Curr Cardiol Rep       Date:  2018-10-11       Impact factor: 2.931

Review 6.  Pathology and Pathogenesis of Chagas Heart Disease.

Authors:  Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

7.  Short treatment with the tumour necrosis factor-alpha blocker infliximab diminishes chronic chagasic myocarditis in rats without evidence of Trypanosoma cruzi reactivation.

Authors:  A R Pérez; G H Fontanella; A L Nocito; S Revelli; O A Bottasso
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

8.  Computational identification of uncharacterized cruzain binding sites.

Authors:  Jacob D Durrant; Henrik Keränen; Benjamin A Wilson; J Andrew McCammon
Journal:  PLoS Negl Trop Dis       Date:  2010-05-11

9.  Role of the gp85/trans-sialidases in Trypanosoma cruzi tissue tropism: preferential binding of a conserved peptide motif to the vasculature in vivo.

Authors:  Renata R Tonelli; Ricardo J Giordano; Elena Magda Barbu; Ana Claudia Torrecilhas; Gerson S Kobayashi; Robert R Langley; Wadih Arap; Renata Pasqualini; Walter Colli; Maria Júlia M Alves
Journal:  PLoS Negl Trop Dis       Date:  2010-11-02

10.  Delivery of antigenic candidates by a DNA/MVA heterologous approach elicits effector CD8(+)T cell mediated immunity against Trypanosoma cruzi.

Authors:  Shivali Gupta; Nisha Jain Garg
Journal:  Vaccine       Date:  2012-10-15       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.